Holen Sie sich die Stockscreener-App
15.59
1.70%
0.26
Handel nachbörslich:
16.00
0.41
+2.63%
Finanzdaten der Neurogene Inc-Aktie (NGNE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 |
| Periodenlänge | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
-2.968 |
Operating Expenses
|
40.97%
18.78
|
31.82 |
| Interest Income/Expense |
0.003
|
- |
| Operating Income/Loss |
40.97%
-18.78
|
-31.82 |
| Income/Loss From Continuing Operations Before Tax |
56.93%
-16.92
|
-39.28 |
| Income/Loss From Continuing Operations After Tax |
9.15%
-16.92
|
-15.50 |
|
Net Income/Loss
|
9.15%
-16.92
|
-15.50 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- |
| Attributable To Noncontrolling Interest |
-
|
- |
| Basic Average Shares |
16.90
|
- |
| Diluted Average Shares |
16.90
|
- |
| Basic Earnings Per Share |
-1.00
|
- |
| Diluted Earnings Per Share |
-1.00
|
- |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):